Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Liver Diseases

Free Subscription Articles published in Dig Dis Sci Retrieve available abstracts of 266 articles: HTML format

Single Articles

April 2024
1. PEARLMAN BL
   Direct-Acting Antiviral Therapy for Patients with Chronic Hepatitis C Infection and Decompensated Cirrhosis.
   Dig Dis Sci. 2024 Apr 5. doi: 10.1007/s10620-024-08393.
   PubMed     Abstract available
   
   
   March 2024
2. WANG H, Liu X, Xie Y, Qin X, et al
   A Case of Immunoglobulin Light Chain Hepatic Amyloidosis with Abdominal Hematoma.
   Dig Dis Sci. 2024 Mar 30. doi: 10.1007/s10620-024-08342.
   PubMed    
   
   
   
3. JAFRI F, Saad S, Riaz H, Saleem F, et al
   Lack of Diversity in Transplant Hepatology Fellowship Program Directorship.
   Dig Dis Sci. 2024 Mar 23. doi: 10.1007/s10620-024-08388.
   PubMed     Abstract available
   
   
   
4. ARSHAD T, Vainer D, Khan H, Baral A, et al
   Development of Clinical Algorithm Utilizing Vibration-Controlled Transient Elastography to Detect Advanced Hepatic Fibrosis in Liver Transplant Recipients.
   Dig Dis Sci. 2024 Mar 18. doi: 10.1007/s10620-024-08366.
   PubMed     Abstract available
   
   
   
5. KAHN-BOESEL O, Mitchell H, Li L, Zhu E, et al
   Hospital-Level Care at Home for Patients with Cirrhosis.
   Dig Dis Sci. 2024 Mar 11. doi: 10.1007/s10620-024-08361.
   PubMed     Abstract available
   
   
   
6. PETROSYAN R, Endres P, Ufere NN, St Hillien SA, et al
   Healthcare Resource Utilization and Goals of Care Discussions in Patients with Cirrhosis and Acute Kidney Injury.
   Dig Dis Sci. 2024 Mar 7. doi: 10.1007/s10620-024-08317.
   PubMed     Abstract available
   
   
   
7. PATEL AA, Walling A, Bansal A
   A New Look at Goals-of-Care Discussions in Patients with Cirrhosis and Acute Kidney Injury.
   Dig Dis Sci. 2024 Mar 7. doi: 10.1007/s10620-024-08300.
   PubMed    
   
   
   
8. REN J, Yao X, Yang M, Cheng S, et al
   Kinesin Family Member-18A (KIF18A) Promotes Cell Proliferation and Metastasis in Hepatocellular Carcinoma.
   Dig Dis Sci. 2024 Mar 6. doi: 10.1007/s10620-024-08321.
   PubMed     Abstract available
   
   
   
9. KIM RG, Patel S, Satre DD, Shumway M, et al
   Telehepatology Satisfaction Is Associated with Ethnicity: The Real-World Experience of a Vulnerable Population with Fatty Liver Disease.
   Dig Dis Sci. 2024;69:732-742.
   PubMed     Abstract available
   
   
   
10. JAROENLAPNOPPARAT A, Mettler SK, Guillen H, Chayanupatkul M, et al
    Changes in the Prevalence, Incidence, and Disability-Adjusted Life Years of Non-alcoholic Fatty Liver Disease in the United States Between 1990 and 2019.
    Dig Dis Sci. 2024;69:702-712.
    PubMed     Abstract available
    
    
    
11. VASSILOPOULOS A, Kalligeros M, Vassilopoulos S, Shehadeh F, et al
    Prevalence of Steatotic Liver Disease Among US Adults with Rheumatoid Arthritis.
    Dig Dis Sci. 2024;69:989-1003.
    PubMed     Abstract available
    
    
    
12. SADLIK G, Anderson RC, Lei X, Cen SY, et al
    Pseudocirrhosis: A Case Series with Clinical and Radiographic Correlation and Review of the Literature.
    Dig Dis Sci. 2024;69:1004-1014.
    PubMed     Abstract available
    
    
    February 2024
13. KALAITZAKIS ZE, Giahnakis E, Koutroubakis IE, Mouzas IA, et al
    Bariatric Nutritional Intervention in Obese Patients with Compensated Liver Cirrhosis: A Four-Year Prospective Study.
    Dig Dis Sci. 2024 Feb 27. doi: 10.1007/s10620-023-08223.
    PubMed     Abstract available
    
    
    
14. ZHAO X, Guo X, Zhao Y, Yu Y, et al
    Gastrointestinal Bleeding Was Diagnosed as Small Intestinal Metastasis of Hepatocellular Carcinoma by Double-Balloon Enteroscopy.
    Dig Dis Sci. 2024 Feb 21. doi: 10.1007/s10620-024-08339.
    PubMed    
    
    
    
15. YE N, Shi X, Gao J, Dong R, et al
    Exosomes from Intrahepatic Cholestasis of Pregnancy Induce Cell Apoptosis Through the miRNA-6891-5p/YWHAE Pathway.
    Dig Dis Sci. 2024 Feb 15. doi: 10.1007/s10620-023-08265.
    PubMed     Abstract available
    
    
    
16. ARE VS, Gromski MA, Akisik F, Vilar-Gomez E, et al
    Primary Sclerosing Cholangitis Limited to Intrahepatic Bile Ducts Has Distinctly Better Prognosis.
    Dig Dis Sci. 2024 Feb 12. doi: 10.1007/s10620-023-08260.
    PubMed     Abstract available
    
    
    
17. MUKUND A, Aravind A, Jindal A, Tevethia HV, et al
    Predictors and Outcomes of Post-transjugular Intrahepatic Portosystemic Shunt Liver Failure in Patients with Cirrhosis.
    Dig Dis Sci. 2024 Feb 10. doi: 10.1007/s10620-023-08256.
    PubMed     Abstract available
    
    
    
18. YILMAZ L, Bulut A, Aytekin A, Baskonus I, et al
    A Novel Technique for the Management of Persistent Biliary Fistulas Developing After Liver Hydatid Cyst Surgeries: Drain Clamping Technique.
    Dig Dis Sci. 2024 Feb 10. doi: 10.1007/s10620-024-08284.
    PubMed     Abstract available
    
    
    
19. LI R, Sarin S
    Disparity Among African Americans in Transjugular Intrahepatic Portosystemic Shunt Procedure: A National Inpatient Sample Analysis from 2015 to 2020.
    Dig Dis Sci. 2024 Feb 6. doi: 10.1007/s10620-024-08273.
    PubMed     Abstract available
    
    
    
20. BATSAIKHAN B, Dai CY
    Treatment of Hepatocellular Carcinoma in the Elderly: Slash or Burn?
    Dig Dis Sci. 2024 Feb 1. doi: 10.1007/s10620-023-08247.
    PubMed    
    
    
    
21. KIM JI, Lee J, Choi GH, Lee MW, et al
    Comparison of Surgical Resection and Radiofrequency Ablation in Elderly Patients with Hepatocellular Carcinoma.
    Dig Dis Sci. 2024 Feb 1. doi: 10.1007/s10620-023-08245.
    PubMed     Abstract available
    
    
    
22. ZEREM E, Denjagic Basic M, Kurtcehajic A, Zerem D, et al
    Indications for the Use of Endoscopic Ultrasound-Guided Liver Biopsy in Patients with Liver Fibrosis.
    Dig Dis Sci. 2024;69:643-644.
    PubMed    
    
    
    
23. ASHKTORAB H, Challa SR, Singh G, Nanduri S, et al
    Gastrointestinal Manifestations and Their Association with Neurologic and Sleep Problems in Long COVID-19 Minority Patients: A Prospective Follow-Up Study.
    Dig Dis Sci. 2024;69:562-569.
    PubMed     Abstract available
    
    
    
24. WAJSBROT NB, Leite NC, Franca PHC, Cardoso CRL, et al
    Parental History of Type 2 Diabetes Mellitus and PNPLA3 Polymorphism Increase the Risk of Severe Stages of Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2024;69:634-642.
    PubMed     Abstract available
    
    
    
25. FIGUEROA G, Castaneda S, McLean H, Dukandar J, et al
    Low Health Literacy, Lack of Knowledge, and Self-Control Hinder Healthy Lifestyles in Diverse Patients with Steatotic Liver Disease.
    Dig Dis Sci. 2024;69:384-398.
    PubMed     Abstract available
    
    
    
26. BEHARI J, Bradley A, Townsend K, Becich MJ, et al
    Limitations of Noninvasive Tests-Based Population-Level Risk Stratification Strategy for Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2024;69:370-383.
    PubMed     Abstract available
    
    
    January 2024
27. HUANG FD, Zhong YP, Sun GY, Xu QJ, et al
    Fanconi Anemia Complementary Group A (FANCA) Facilitates the Occurrence and Progression of Liver Hepatocellular Carcinoma.
    Dig Dis Sci. 2024 Jan 28. doi: 10.1007/s10620-024-08282.
    PubMed     Abstract available
    
    
    
28. ASADA S, Namisaki T, Kaji K, Takaya H, et al
    VWF/ADAMTS13 Ratio as a Potential Predictive Biomarker for Acute Kidney Injury Onset in Cirrhosis.
    Dig Dis Sci. 2024 Jan 20. doi: 10.1007/s10620-023-08257.
    PubMed     Abstract available
    
    
    
29. BOWMAN CA, Bichoupan K, Posner S, Schonfeld E, et al
    A Prospective Open-Label Dose-Response Study to Correct Vitamin D Deficiency in Cirrhosis.
    Dig Dis Sci. 2024 Jan 13. doi: 10.1007/s10620-023-08224.
    PubMed     Abstract available
    
    
    
30. TSAI SY, O'Leary JG
    Optimizing Outcomes in Patients with Ascites Complicating Cirrhosis-Maximizing the Hour of Power.
    Dig Dis Sci. 2024 Jan 13. doi: 10.1007/s10620-023-08255.
    PubMed    
    
    
    
31. BADAL J, Badal B, Nawras M, Lee-Smith W, et al
    Diagnostic Paracentesis Within 1 Day Is Associated With Reduced Mortality and Length of Hospital Stay in Patients with Cirrhosis and Ascites.
    Dig Dis Sci. 2024 Jan 13. doi: 10.1007/s10620-023-08249.
    PubMed     Abstract available
    
    
    
32. LIN W, Zhao Z, Du W, Ni Z, et al
    Interferon-Gamma-Inducible Protein 16 Inhibits Hepatocellular Carcinoma via Interferon Regulatory Factor 3 on Chemosensitivity.
    Dig Dis Sci. 2024 Jan 3. doi: 10.1007/s10620-023-08175.
    PubMed     Abstract available
    
    
    
33. BLOOM PP, Che Z, Hyde A, Johnson E, et al
    Development and Evaluation of a Patient Cirrhosis Knowledge Assessment.
    Dig Dis Sci. 2024 Jan 3. doi: 10.1007/s10620-023-08238.
    PubMed     Abstract available
    
    
    December 2023
34. JAMES M, Alazawi W
    Non-invasive Tests of Fibrosis: Does One Size Fit All?
    Dig Dis Sci. 2023;68:4285-4286.
    PubMed    
    
    
    
35. ARORA U, Goyal RM, Teh KKJ, Pei Y, et al
    Poor Performance of Non-invasive Tests for Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: A Multicentric Asian Study.
    Dig Dis Sci. 2023;68:4485-4498.
    PubMed     Abstract available
    
    
    November 2023
36. SUN Y, Lu M, Feldman R, Saul M, et al
    Positive Predictive Value of Cirrhosis and Chronic Pancreatitis Diagnoses in Individuals with Alcohol Use Disorder: A Single-Center Study.
    Dig Dis Sci. 2023 Nov 29. doi: 10.1007/s10620-023-08183.
    PubMed     Abstract available
    
    
    
37. SOHAL A, Kohli I, Chaudhry H, Singh I, et al
    Vaccine-Preventable Illness Leads to Adverse Outcomes in Liver Transplant Recipients.
    Dig Dis Sci. 2023 Nov 29. doi: 10.1007/s10620-023-08202.
    PubMed     Abstract available
    
    
    
38. WONG ZY, Koh JH, Muthiah M, Koh B, et al
    Proton Pump Inhibitors Increases Longitudinal Risk of Mortality, Decompensation, and Infection in Cirrhosis: A Meta-Analysis.
    Dig Dis Sci. 2023 Nov 15. doi: 10.1007/s10620-023-08150.
    PubMed     Abstract available
    
    
    
39. LOW EXS, Wang YP, Lu CL
    Risks of Proton Pump Inhibitors in Patients with Cirrhosis: Please Peruse the Indications.
    Dig Dis Sci. 2023 Nov 15. doi: 10.1007/s10620-023-08153.
    PubMed     Abstract available
    
    
    October 2023
40. JINDAL A, Sharma MK, Vijayaraghavan R, Sm S, et al
    Severity of Acute Portal Hypertension Determines the Clinical Outcomes in Severe Alcoholic Hepatitis.
    Dig Dis Sci. 2023 Oct 31. doi: 10.1007/s10620-023-08144.
    PubMed     Abstract available
    
    
    
41. GONZALEZ HC, Trudeau S
    COVID-19 + Cirrhosis = Excess Hospital Confinement, Excess Casualties.
    Dig Dis Sci. 2023 Oct 21. doi: 10.1007/s10620-023-08106.
    PubMed    
    
    
    
42. TWOHIG PA, Scholten K, Schissel M, Brittan K, et al
    Mortality Increased Among Hospitalized Patients with Cirrhosis Before and Following Different Waves of the COVID-19 Pandemic.
    Dig Dis Sci. 2023 Oct 21. doi: 10.1007/s10620-023-08105.
    PubMed     Abstract available
    
    
    
43. BANGARU S, Sundaresh R, Lee A, Prause N, et al
    Predictive Algorithm for Hepatic Steatosis Detection Using Elastography Data in the Veterans Affairs Electronic Health Records.
    Dig Dis Sci. 2023 Oct 21. doi: 10.1007/s10620-023-08043.
    PubMed     Abstract available
    
    
    
44. KILANI Y, Kamal SAF, Vikash F, Vikash S, et al
    Correction to: Racial Disparities in Liver Transplantation for Hepatocellular Carcinoma in the United States: An Update.
    Dig Dis Sci. 2023 Oct 13. doi: 10.1007/s10620-023-08131.
    PubMed    
    
    
    
45. WANG L, Zhang Y, Li J, Guo S, et al
    A Nomogram of Magnetic Resonance Imaging for Preoperative Assessment of Microvascular Invasion and Prognosis of Hepatocellular Carcinoma.
    Dig Dis Sci. 2023 Oct 4. doi: 10.1007/s10620-023-08022.
    PubMed     Abstract available
    
    
    
46. DAKROUB A, Anouti A, Cotter TG, Lee WM, et al
    Mortality and Morbidity Among Adult Liver Retransplant Recipients.
    Dig Dis Sci. 2023;68:4039-4049.
    PubMed     Abstract available
    
    
    
47. KAUR P, Verma N, Valsan A, Garg P, et al
    Prevalence, Risk Factors, and Impact of Bacterial or Fungal Infections in Acute Liver Failure Patients from India.
    Dig Dis Sci. 2023;68:4022-4038.
    PubMed     Abstract available
    
    
    
48. SMAYRA K, Miangul S, Yap N, Shi A, et al
    Technical Success, Sample Adequacy, and Complications of Pediatric Transjugular Liver Biopsy: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2023;68:3846-3856.
    PubMed     Abstract available
    
    
    
49. LI R, Li M, Bidulescu A, Fly AD, et al
    Diets with Higher Anti-inflammatory Potential Associated with Lower Risk of Development of Nonalcoholic Fatty Liver Disease and Early-Stage of Fibrosis Among US Adults.
    Dig Dis Sci. 2023;68:4009-4021.
    PubMed     Abstract available
    
    
    September 2023
50. GOBLE S, Akambase J, Prieto J, Balderramo D, et al
    MBOAT7 rs641738 Variant Is Not Associated with an Increased Risk of Hepatocellular Carcinoma in a Latin American Cohort.
    Dig Dis Sci. 2023 Sep 8. doi: 10.1007/s10620-023-08104.
    PubMed     Abstract available
    
    
    
51. CHOI AY, Li X, Guo W, Chandan VS, et al
    Performance of Endoscopic Ultrasound-Guided Versus Percutaneous Liver Biopsy in Diagnosing Stage 3-4 Fibrosis.
    Dig Dis Sci. 2023;68:3774-3780.
    PubMed     Abstract available
    
    
    
52. MCNALLY BB, Rangan P, Wijarnpreecha K, Fallon MB, et al
    Fibrosis-4 Index Score Predicts Concomitant Coronary Artery Diseases Across the Spectrum of Fatty Liver Disease.
    Dig Dis Sci. 2023;68:3765-3773.
    PubMed     Abstract available
    
    
    August 2023
53. KILANI Y, Kamal SAF, Vikash F, Vikash S, et al
    Racial Disparities in Liver Transplantation for Hepatocellular Carcinoma in the United States: An Update.
    Dig Dis Sci. 2023 Aug 16. doi: 10.1007/s10620-023-08084.
    PubMed     Abstract available
    
    
    July 2023
54. TAPPER EB, Saleh ZM, Lizza S, Chen X, et al
    CAREGIVER Randomized Trial of Two Mindfulness Methods to Improve the Burden and Distress of Caring for Persons with Cirrhosis.
    Dig Dis Sci. 2023 Jul 27. doi: 10.1007/s10620-023-08042.
    PubMed     Abstract available
    
    
    
55. ROY S, Mewara A, Gupta R, Rana SS, et al
    Endoscopic Diagnosis of Biliary Fascioliasis in Non-endemic Region.
    Dig Dis Sci. 2023 Jul 27. doi: 10.1007/s10620-023-08045.
    PubMed    
    
    
    
56. SUAREZ M, Martinez R, Torres AM, Torres B, et al
    A Machine Learning Method to Identify the Risk Factors for Liver Fibrosis Progression in Nonalcoholic Steatohepatitis.
    Dig Dis Sci. 2023 Jul 21. doi: 10.1007/s10620-023-08031.
    PubMed     Abstract available
    
    
    
57. THANAKUNCHAI T, Hongthanakorn C
    Prevalence and Risk Factors of Post-chemoembolization Syndrome After Chemo-Embolization for Hepatocellular Carcinoma in Thailand.
    Dig Dis Sci. 2023 Jul 4. doi: 10.1007/s10620-023-08010.
    PubMed     Abstract available
    
    
    
58. MOORE JA, Wheless WH, Zhang J, Marsden J, et al
    Gaps in Confirmatory Fibrosis Risk Assessment in Primary Care Patients with Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2023;68:2946-2953.
    PubMed     Abstract available
    
    
    
59. BROWN C, Aksan N, Chang P, Jagannathan P, et al
    Delayed Diagnostic Paracentesis Is Associated with Increased Preventable Healthcare Utilization in Disadvantaged Patient Populations with Advanced Liver Disease and Elevated INR.
    Dig Dis Sci. 2023;68:2954-2962.
    PubMed     Abstract available
    
    
    June 2023
60. WENTWORTH BJ, Khot R, Caldwell SH
    The Many Faces of Primary Sclerosing Cholangitis: Controversy Abounds.
    Dig Dis Sci. 2023 Jun 26. doi: 10.1007/s10620-023-08003.
    PubMed     Abstract available
    
    
    
61. ATTANASI ML, Bou Daher H, Rockey DC
    Natural History and Outcomes of Cavernous Transformation of the Portal Vein in Cirrhosis.
    Dig Dis Sci. 2023 Jun 22. doi: 10.1007/s10620-023-07993.
    PubMed     Abstract available
    
    
    
62. ALUKAL JJ, Li F, Thuluvath PJ
    Liver Transplantation Within 7-Days of Listing Improves Survival in ACLF-3.
    Dig Dis Sci. 2023 Jun 21. doi: 10.1007/s10620-023-08011.
    PubMed     Abstract available
    
    
    
63. MCHENRY S, Awad A, Kozlitina J, Stitziel NO, et al
    Low LDL Cholesterol Is Not an Independent Risk Factor for Hepatic Steatosis.
    Dig Dis Sci. 2023 Jun 8. doi: 10.1007/s10620-023-07980.
    PubMed     Abstract available
    
    
    
64. OBRI MS, Youssef RM, Alluri S, Vemulapalli K, et al
    Disparities in Referrals to End-of-Life Care in Eligible Hepatocellular Carcinoma Patients.
    Dig Dis Sci. 2023 Jun 8. doi: 10.1007/s10620-023-07992.
    PubMed     Abstract available
    
    
    
65. CHENG KL, Cheng YM, Chan CY, Wang CC, et al
    Predictors of Liver Dysfunction After Transhepatic Arterial Chemo-embolization in Hepatocellular Carcinoma Patients.
    Dig Dis Sci. 2023 Jun 2. doi: 10.1007/s10620-023-07984.
    PubMed     Abstract available
    
    
    
66. BOU DAHER H, Manka P, Syn WK
    Settling the Score: Which Fibrosis Screening Tool Is the Most Reliable for Nonalcoholic Fatty Liver Disease?
    Dig Dis Sci. 2023;68:2217-2220.
    PubMed    
    
    
    
67. BERTOT LC, Jeffrey GP, de Boer B, Wang Z, et al
    Comparative Accuracy of Clinical Fibrosis Markers, Hepascore and Fibroscan(R) to Detect Advanced Fibrosis in Patients with Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2023;68:2757-2767.
    PubMed     Abstract available
    
    
    May 2023
68. MUNOZ AE, Pollarsky F, Marino M, Cartier M, et al
    Baseline Severity and Inflammation Would Influence the Effect of Simvastatin on Clinical Outcomes in Cirrhosis Patients.
    Dig Dis Sci. 2023 May 22. doi: 10.1007/s10620-023-07969.
    PubMed     Abstract available
    
    
    
69. KAPLAN DE
    Statins in Cirrhosis: Trial Data Are in but the Jury Is Still Out.
    Dig Dis Sci. 2023 May 22. doi: 10.1007/s10620-023-07970.
    PubMed    
    
    
    
70. MUKUND A, Marri UK, Jindal A, Choudhury A, et al
    Safety and Efficacy of Transjugular Intrahepatic Portosystemic Shunt for Non-tumoral Cirrhotic Portal Vein Thrombosis Not Responding to Anticoagulation Therapy.
    Dig Dis Sci. 2023 May 12. doi: 10.1007/s10620-023-07930.
    PubMed     Abstract available
    
    
    
71. SANDHU S, John BV
    Spontaneous Bacterial Peritonitis: The Bug Matters.
    Dig Dis Sci. 2023;68:1667-1669.
    PubMed    
    
    
    
72. FUREY C, Zhou S, Park JH, Foong A, et al
    Impact of Bacteria Types on the Clinical Outcomes of Spontaneous Bacterial Peritonitis.
    Dig Dis Sci. 2023;68:2140-2148.
    PubMed     Abstract available
    
    
    
73. DEVARBHAVI H, Sridhar A, Kurien SS, Gowda V, et al
    Clinical and Liver Biochemistry Phenotypes, and Outcome in 133 Patients with Anti-seizure Drug-Induced Liver Injury.
    Dig Dis Sci. 2023;68:2099-2106.
    PubMed     Abstract available
    
    
    April 2023
74. CHOW KW, Ibrahim BM, Yum JJ, Dang A, et al
    Barriers to Lactulose Adherence in Patients with Cirrhosis and Hepatic Encephalopathy.
    Dig Dis Sci. 2023 Apr 29. doi: 10.1007/s10620-023-07935.
    PubMed     Abstract available
    
    
    
75. RUSTAM LB, Vander Weg M, Chrischilles E, Tanaka T, et al
    Sociodemographic and Clinical Factors Associated with Nonattendance at the Hepatology Clinic.
    Dig Dis Sci. 2023 Apr 27. doi: 10.1007/s10620-023-07951.
    PubMed     Abstract available
    
    
    
76. GARG R, Mohammed A, Singh A, Siddiki H, et al
    Mortality Trends, Outcomes, and Predictors of Portal Vein Thrombosis in Acute Pancreatitis Patients: A Propensity-Matched National Study.
    Dig Dis Sci. 2023 Apr 25. doi: 10.1007/s10620-023-07945.
    PubMed     Abstract available
    
    
    
77. PATERNOSTRO R
    Muscle Mass Effect: The Importance of Diagnosing and Treating Sarcopenia in Patients with Advanced Chronic Liver Disease.
    Dig Dis Sci. 2023;68:1089-1090.
    PubMed    
    
    
    
78. UNALP-ARIDA A, Ruhl CE
    Prepandemic Prevalence Estimates of Fatty Liver Disease and Fibrosis Defined by Liver Elastography in the United States.
    Dig Dis Sci. 2023;68:1237-1252.
    PubMed     Abstract available
    
    
    
79. MAHMUD N, Reddy KR, Taddei TH, Kaplan DE, et al
    Type of Infection Is Associated with Prognosis in Acute-on-Chronic Liver Failure: A National Veterans Health Administration Study.
    Dig Dis Sci. 2023;68:1632-1640.
    PubMed     Abstract available
    
    
    March 2023
80. ZHI SC, Chen SZ, Li YY, Li JJ, et al
    Retraction Note: Rosiglitazone Inhibits Activation of Hepatic Stellate Cells via Up-Regulating Micro-RNA-124-3p to Alleviate Hepatic Fibrosis.
    Dig Dis Sci. 2023 Mar 29. doi: 10.1007/s10620-023-07926.
    PubMed    
    
    
    
81. PROTOPAPAS AA, Savopoulos C, Skoura L, Goulis I, et al
    Anticoagulation in Patients with Liver Cirrhosis: Friend or Foe?
    Dig Dis Sci. 2023 Mar 24. doi: 10.1007/s10620-023-07858.
    PubMed     Abstract available
    
    
    
82. SMITH HT, de Souza AR, Thompson AH, McLaughlin MM, et al
    Cholestatic Pruritus Treatments in Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: A Systematic Literature Review.
    Dig Dis Sci. 2023 Mar 18:1-21. doi: 10.1007/s10620-023-07862.
    PubMed     Abstract available
    
    
    
83. GOODMAN MC, Chesner JH, Pourmand K, Farouk SS, et al
    Developing a Novel Case-Based Gastroenterology/Hepatology Online Resource for Enhanced Education During and After the COVID-19 Pandemic.
    Dig Dis Sci. 2023 Mar 15. doi: 10.1007/s10620-023-07910.
    PubMed     Abstract available
    
    
    
84. KHALIFA A, Obeid JS, Gregoski MJ, Rockey DC, et al
    Accurate Identification of Patients with Cirrhosis and Its Complications in the Electronic Health Record.
    Dig Dis Sci. 2023 Mar 10. doi: 10.1007/s10620-023-07876.
    PubMed     Abstract available
    
    
    
85. JAFRI FI, de Montfort Shepherd A, Raman P, Varkey TC, et al
    Transplant Hepatology Fellowship Websites: The Good, the Bad, and the Unhelpful.
    Dig Dis Sci. 2023 Mar 7:1-5. doi: 10.1007/s10620-023-07887.
    PubMed    
    
    
    
86. JAMMA T
    SALL4 Expression in Epithelial Gastric Cancer: Epigenetic or Epiphenomenon?
    Dig Dis Sci. 2023 Mar 6. doi: 10.1007/s10620-022-07791.
    PubMed    
    
    
    
87. CALMET FH, Martin P
    Acid Test: MELD-Lactate Enhances Prediction in Patients with Variceal Hemorrhage.
    Dig Dis Sci. 2023;68:723-724.
    PubMed    
    
    
    
88. SINGAL AG, Parikh ND, Hoshida Y
    Precision HCC Surveillance: It Is All in the Number (Needed).
    Dig Dis Sci. 2023;68:720-722.
    PubMed    
    
    
    
89. AGGARWAL M, Garg R, Parthasarthy G, Nowacki AS, et al
    Crohn's Disease Is Associated with Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2023;68:1006-1015.
    PubMed     Abstract available
    
    
    
90. ELHENCE A, Anand A, Biswas S, Vaishnav M, et al
    Compensated Advanced Chronic Liver Disease in Nonalcoholic Fatty Liver Disease: Two-Step Strategy is Better than Baveno Criteria.
    Dig Dis Sci. 2023;68:1016-1025.
    PubMed     Abstract available
    
    
    February 2023
91. YANG Y, Sun JH, Tan XY, Lu CD, et al
    MTM-HCC at Previous Liver Resection as a Predictor of Overall Survival in Salvage Liver Transplantation.
    Dig Dis Sci. 2023 Feb 15. doi: 10.1007/s10620-023-07857.
    PubMed     Abstract available
    
    
    
92. DUKEWICH M, Liu CH, Weinberg EM, Mahmud N, et al
    Clinical Predictors of Intensive Care Unit Transfer in Admitted Patients with Cirrhosis.
    Dig Dis Sci. 2023 Feb 12. doi: 10.1007/s10620-023-07856.
    PubMed     Abstract available
    
    
    
93. SHEN S, Huang H, Wang J, Tang Z, et al
    Positive Association Between the Chinese Visceral Adiposity Index and Nonalcoholic Fatty Liver Disease in Lean Adults.
    Dig Dis Sci. 2023;68:656-664.
    PubMed     Abstract available
    
    
    
94. ISLAM KB, Brandman D, Chu JN, Goldman ML, et al
    Primary Care Providers and Nonalcoholic Fatty Liver Disease: A Needs Assessment Survey.
    Dig Dis Sci. 2023;68:434-438.
    PubMed     Abstract available
    
    
    
95. LV L, Wang D, Yin J, Yang T, et al
    Downregulation of miR-20b-5p Contributes to the Progression of Liver Fibrosis via the STAT3 Signaling Pathway In Vivo and In Vitro.
    Dig Dis Sci. 2023;68:487-496.
    PubMed     Abstract available
    
    
    
96. KHAN S, Kalkwarf HJ, Hornung L, Siegel R, et al
    Histologic Severity of Nonalcoholic Fatty Liver Disease Associates with Reduced Bone Mineral Density in Children.
    Dig Dis Sci. 2023;68:644-655.
    PubMed     Abstract available
    
    
    January 2023
97. SONG J, Wang X, Yan Y, Xiang T, et al
    MELD 3.0 Score for Predicting Survival in Patients with Cirrhosis After Transjugular Intrahepatic Portosystemic Shunt Creation.
    Dig Dis Sci. 2023 Jan 30. doi: 10.1007/s10620-023-07834.
    PubMed     Abstract available
    
    
    
98. DAHMUS J, Hummer B, Rivas G, Schmitz K, et al
    Patients with Nonalcoholic Steatohepatitis and Advanced Liver Disease Have the Lowest Cardiorespiratory Fitness.
    Dig Dis Sci. 2023 Jan 24. doi: 10.1007/s10620-022-07809.
    PubMed     Abstract available
    
    
    
99. LI H, Lan H, Zhang M, Zhao F, et al
    TEA Domain Transcription Factor 1 Inhibits Ferroptosis and Sorafenib Sensitivity of Hepatocellular Carcinoma Cells.
    Dig Dis Sci. 2023 Jan 21. doi: 10.1007/s10620-023-07824.
    PubMed     Abstract available
    
    
    December 2022
100. LI T, Liu J, Zhao J, Bai Y, et al
     Sarcopenia Defined by Psoas Muscle Thickness Predicts Mortality After Transjugular Intrahepatic Portosystemic Shunt.
     Dig Dis Sci. 2022 Dec 30. doi: 10.1007/s10620-022-07806.
     PubMed     Abstract available
     
     
     
101. WANG H, Chen W, Qi Y, Liu D, et al
     miR-29c Suppresses the Malignant Phenotype of Hepatocellular Carcinoma Cells In Vitro by Mediating TPX2 Associated with Immune Infiltration.
     Dig Dis Sci. 2022 Dec 30. doi: 10.1007/s10620-022-07810.
     PubMed     Abstract available
     
     
     
102. RUDNICK SR, Ugwuegbu J, Soufleris SJ, Bundy R, et al
     Telephone-Only Visits Preserved Hepatocellular Cancer Screening Rates in Patients with Cirrhosis Early in the COVID-19 Pandemic.
     Dig Dis Sci. 2022 Dec 23. doi: 10.1007/s10620-022-07786.
     PubMed     Abstract available
     
     
     
103. JINDAL A, Agarwal S, Sharma S, Kumar M, et al
     Assessment of the Performance of Non-invasive Criteria for the Evaluation of Clinically Significant Portal Hypertension in Patients with Compensated Advanced Chronic Liver Disease.
     Dig Dis Sci. 2022 Dec 23. doi: 10.1007/s10620-022-07778.
     PubMed     Abstract available
     
     
     
104. WANG ZJ, Lv XH, Yang JL
     Methodological Issues to Be Considered in Evaluating Advanced Endoscopic Resection Techniques in Cirrhosis.
     Dig Dis Sci. 2022 Dec 20. doi: 10.1007/s10620-022-07767.
     PubMed    
     
     
     
105. KEATING SE, Croci I, Wallen MP, Cox ER, et al
     High-Intensity Interval Training is Safe, Feasible and Efficacious in Nonalcoholic Steatohepatitis: A Randomized Controlled Trial.
     Dig Dis Sci. 2022 Dec 20:1-17. doi: 10.1007/s10620-022-07779.
     PubMed     Abstract available
     
     
     November 2022
106. CHENG S, Yu E, Garacci Z, Erwin AL, et al
     Prevalence of Undiagnosed Acute Hepatic Porphyria in Cyclic Vomiting Syndrome and Overlap in Clinical Symptoms.
     Dig Dis Sci. 2022 Nov 16. pii: 10.1007/s10620-022-07756.
     PubMed     Abstract available
     
     
     
107. HORVATITS T, Mahmud N, Serper M, Seiz O, et al
     MELD-Lactate Predicts Poor Outcome in Variceal Bleeding in Cirrhosis.
     Dig Dis Sci. 2022 Nov 14. pii: 10.1007/s10620-022-07744.
     PubMed     Abstract available
     
     
     
108. CURRAN C, Priest M, Datta S, Forrest EH, et al
     Hepatocellular Carcinoma Risk Scores Predict Patients Under Surveillance at Low Risk of Benefit and High Risk of Harm.
     Dig Dis Sci. 2022 Nov 14. pii: 10.1007/s10620-022-07731.
     PubMed     Abstract available
     
     
     
109. INOUE T, Kitano R, Ibusuki M, Sakamoto K, et al
     Endoscopic Ultrasound-Guided Hepaticogastrostomy with Antegrade Stenting Without Dilation Device Application for Malignant Distal Biliary Obstruction in Pancreatic Cancer.
     Dig Dis Sci. 2022 Nov 9. pii: 10.1007/s10620-022-07749.
     PubMed     Abstract available
     
     
     
110. TAPPER EB, Zhao Z, Mazumder N, Parikh ND, et al
     Incidence of, Risk Factors for, and Outcomes After Ascites in a Population-Based Cohort of Older Americans.
     Dig Dis Sci. 2022;67:5327-5335.
     PubMed     Abstract available
     
     
     
111. SARAIREH H, Abdelfattah T, Hassouneh R, Lippman R, et al
     "Wet Heparin" and "Wet Saline" EUS-Guided Liver Biopsy Techniques Both Provide High Rates of Specimen Adequacy for Benign Parenchymal Liver Disease.
     Dig Dis Sci. 2022;67:5256-5261.
     PubMed     Abstract available
     
     
     
112. YEBOAH-KORANG A, Memon A, Patel N, Portocarrero-Castillo A, et al
     Impact of Prior Drug Allergies on the Risk, Clinical Features, and Outcomes of Idiosyncratic Drug-Induced Liver Injury in Adults.
     Dig Dis Sci. 2022;67:5262-5271.
     PubMed     Abstract available
     
     
     
113. CARDOSO AC, Tovo CV, Leite NC, El Bacha IA, et al
     Validation and Performance of FibroScan(R)-AST (FAST) Score on a Brazilian Population with Nonalcoholic Fatty Liver Disease.
     Dig Dis Sci. 2022;67:5272-5279.
     PubMed     Abstract available
     
     
     October 2022
114. LIU YC, Cheng YT, Chen YC, Hsieh YC, et al
     Correction: Comparing Predictability of Noninvasive Tools for Hepatocellular Carcinoma in Treated Chronic Hepatitis C Patients.
     Dig Dis Sci. 2022 Oct 17. pii: 10.1007/s10620-022-07683.
     PubMed    
     
     
     
115. SCHEINBERG AR, John BV
     MAFLD Versus NAFLD: Which Better Predicts the Risk of Atherosclerotic Cardiovascular Disease?
     Dig Dis Sci. 2022;67:4606-4608.
     PubMed    
     
     
     
116. KIM H, Lee CJ, Ahn SH, Lee KS, et al
     MAFLD Predicts the Risk of Cardiovascular Disease Better than NAFLD in Asymptomatic Subjects with Health Check-Ups.
     Dig Dis Sci. 2022;67:4919-4928.
     PubMed     Abstract available
     
     
     
117. GIRI S, Darak H, Kasturi S
     Benefit of Antiviral Therapy for HBV-Related HCC with Undetectable HBV DNA Is Still Dubious.
     Dig Dis Sci. 2022;67:4962-4964.
     PubMed    
     
     
     
118. ASHOURI Y, Hsu CH, Riall TS, Konstantinidis IT, et al
     Aspartate Aminotransferase-to-Platelet Ratio Index Predicts Liver Failure After Resection of Colorectal Liver Metastases.
     Dig Dis Sci. 2022;67:4950-4958.
     PubMed     Abstract available
     
     
     September 2022
119. KHAKOO NS, Sultan S, Reynolds JM, Levy C, et al
     Efficacy and Safety of Bezafibrate Alone or in Combination with Ursodeoxycholic Acid in Primary Biliary Cholangitis: Systematic Review and Meta-Analysis.
     Dig Dis Sci. 2022 Sep 30. pii: 10.1007/s10620-022-07704.
     PubMed     Abstract available
     
     
     
120. BENSON M, Gopal D, Pfau P
     Electronic Health Record Work Demands for Gastroenterology and Hepatology Providers: A Prospective Use Analysis and Survey Study.
     Dig Dis Sci. 2022 Sep 28. pii: 10.1007/s10620-022-07691.
     PubMed     Abstract available
     
     
     
121. SINGH A, De A, Singh MP, Rathi S, et al
     Antibody Response and Safety of ChAdOx1-nCOV (Covishield) in Patients with Cirrhosis: A Cross-Sectional, Observational Study.
     Dig Dis Sci. 2022 Sep 25. pii: 10.1007/s10620-022-07641.
     PubMed     Abstract available
     
     
     
122. HARTGERINK C, Nimri FM, Zuchelli T, Jafri SM, et al
     Band Ligation Can Be Used to Treat Barrett's Esophagus and Concurrent Esophageal Varices: A Case Series.
     Dig Dis Sci. 2022 Sep 21. pii: 10.1007/s10620-022-07696.
     PubMed     Abstract available
     
     
     
123. LIU BD, Qureshi K
     Secondary Treatment of Primary Biliary Cholangitis: Early Prediction of Inadequate Response to Ursodeoxycholic Acid in Patients with PBC.
     Dig Dis Sci. 2022 Sep 13. pii: 10.1007/s10620-022-07661.
     PubMed    
     
     
     
124. CHAPIN SE, Goldberg DS, Kaplan DE, Mahmud N, et al
     External Validation of the FIPS Score for Post-TIPS Mortality in a National Veterans Affairs Cohort.
     Dig Dis Sci. 2022;67:4581-4589.
     PubMed     Abstract available
     
     
     August 2022
125. AMES PRJ, D'Andrea G, Arcaro A, Marottoli V, et al
     Liver Cirrhosis Patients Homozygous for MTHFR C677T Develop Portal Vein Thrombosis 8 Years Earlier Than Wild Type.
     Dig Dis Sci. 2022 Aug 24. pii: 10.1007/s10620-022-07666.
     PubMed     Abstract available
     
     
     
126. CANCADO GGL, Couto CA, Terrabuio DRB, Cancado ELR, et al
     Response to Ursodeoxycholic Acid May Be Assessed Earlier to Allow Second-Line Therapy in Patients with Unresponsive Primary Biliary Cholangitis.
     Dig Dis Sci. 2022 Aug 22. pii: 10.1007/s10620-022-07654.
     PubMed     Abstract available
     
     
     
127. PREMKUMAR M, Mehtani R, Kulkarni AV, Duseja AK, et al
     Association of Heparin-Like Effect, Factor VII/XIII Deficiency and Fibrinolysis with Rebleeding Risk in Cirrhosis with Acute Variceal Bleeding.
     Dig Dis Sci. 2022 Aug 19. pii: 10.1007/s10620-022-07656.
     PubMed     Abstract available
     
     
     
128. FERREIRA RD, John BV
     Viral Vector Vaccines Are Victorious Against COVID-19 in Patients with Cirrhosis.
     Dig Dis Sci. 2022 Aug 10. pii: 10.1007/s10620-022-07644.
     PubMed    
     
     
     
129. SAKANO Y, Noda T, Kobayashi S, Kitagawa A, et al
     Clinical Significance of Acylphosphatase 1 Expression in Combined HCC-iCCA, HCC, and iCCA.
     Dig Dis Sci. 2022;67:3817-3830.
     PubMed     Abstract available
     
     
     
130. SOBOTKA LA, Esteban J, Volk ML, Elmunzer BJ, et al
     Acute Liver Injury in Patients Hospitalized with COVID-19.
     Dig Dis Sci. 2022;67:4204-4214.
     PubMed     Abstract available
     
     
     
131. RAJAK S, Raza S, Tewari A, Sinha RA, et al
     Environmental Toxicants and NAFLD: A Neglected yet Significant Relationship.
     Dig Dis Sci. 2022;67:3497-3507.
     PubMed     Abstract available
     
     
     July 2022
132. LIU YC, Cheng YT, Chen YC, Hsieh YC, et al
     Comparing Predictability of Non-invasive Tools for Hepatocellular Carcinoma in Treated Chronic Hepatitis C Patients Characters: 102 (< 120).
     Dig Dis Sci. 2022 Jul 27. pii: 10.1007/s10620-022-07621.
     PubMed     Abstract available
     
     
     
133. MANDORFER M
     Individualization of HCC and Portal Hypertension Surveillance in Patients with Compensated Advanced Chronic Liver Disease and SVR.
     Dig Dis Sci. 2022 Jul 27. pii: 10.1007/s10620-022-07623.
     PubMed    
     
     
     
134. ADAMS PC
     Hepatocellular Carcinoma in Hemochromatosis: Where or When?
     Dig Dis Sci. 2022 Jul 11. pii: 10.1007/s10620-022-07609.
     PubMed    
     
     
     
135. NATARAJAN Y, Patel P, Chu J, Yu X, et al
     Risk of Hepatocellular Carcinoma in Patients with Various HFE Genotypes.
     Dig Dis Sci. 2022 Jul 5. pii: 10.1007/s10620-022-07602.
     PubMed     Abstract available
     
     
     
136. IZZY M, VanWagner LB
     Analyzing the Different Prevalence for Cirrhotic Cardiomyopathy in Different Studies.
     Dig Dis Sci. 2022 Jul 5. pii: 10.1007/s10620-022-07580.
     PubMed    
     
     
     
137. YARRA P, Dunn W, Younossi Z, Kuo YF, et al
     Association of Previous Gastric Bypass Surgery and Patient Outcomes in Alcohol-Associated Cirrhosis Hospitalizations.
     Dig Dis Sci. 2022 Jul 4. pii: 10.1007/s10620-022-07591.
     PubMed     Abstract available
     
     
     
138. RAMAI D, Facciorusso A, Singh J, Brooks OW, et al
     Endoscopic Management of Ampullary Adenomas in Familial Adenomatous Polyposis Syndrome: A Systematic Review with Pooled Analysis.
     Dig Dis Sci. 2022;67:3220-3227.
     PubMed     Abstract available
     
     
     
139. ELFEKI MA, Robles J, Akhtar Z, Ullah F, et al
     Impact of Fibrosis-4 Index Prior to COVID-19 on Outcomes in Patients at Risk of Non-alcoholic Fatty Liver Disease.
     Dig Dis Sci. 2022;67:3333-3339.
     PubMed     Abstract available
     
     
     
140. FUNG BM, Leon DJ, Beck LN, Tabibian JH, et al
     Pre-procedural Preparation and Sedation for Gastrointestinal Endoscopy in Patients with Advanced Liver Disease.
     Dig Dis Sci. 2022;67:2739-2753.
     PubMed     Abstract available
     
     
     
141. GARCIA CC, Piotrkowski B, Baz P, Poncino D, et al
     A Decreased Response to Resistin in Mononuclear Leukocytes Contributes to Oxidative Stress in Nonalcoholic Fatty Liver Disease.
     Dig Dis Sci. 2022;67:3006-3016.
     PubMed     Abstract available
     
     
     
142. THOMAIDES-BREARS HB, Alkhouri N, Allende D, Harisinghani M, et al
     Incidence of Complications from Percutaneous Biopsy in Chronic Liver Disease: A Systematic Review and Meta-Analysis.
     Dig Dis Sci. 2022;67:3366-3394.
     PubMed     Abstract available
     
     
     June 2022
143. DIJOSEPH K, Thorp A, Harrington A, Schmitz KH, et al
     Physical Activity and Risk of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
     Dig Dis Sci. 2022 Jun 29. pii: 10.1007/s10620-022-07601.
     PubMed     Abstract available
     
     
     
144. VIJAYARAGHAVAN R, Sarin SK, Bharadwaj A, Anand L, et al
     Intragastric Balloon in Obese Compensated Nonalcoholic Steatohepatitis Cirrhosis Patients Is Safe and Achieves Significant Weight Reduction at 6-Months.
     Dig Dis Sci. 2022 Jun 28. pii: 10.1007/s10620-022-07596.
     PubMed     Abstract available
     
     
     
145. CHU J, Cholankeril G, Yu X, Rana A, et al
     Clinical Course and Outcomes of Patients with Nonalcoholic Fatty Liver Disease-Related Hepatocellular Cancer (NAFLD-HCC).
     Dig Dis Sci. 2022 Jun 27. pii: 10.1007/s10620-022-07565.
     PubMed     Abstract available
     
     
     
146. MAYO MJ, Carey E, Smith HT, Mospan AR, et al
     Impact of Pruritus on Quality of Life and Current Treatment Patterns in Patients with Primary Biliary Cholangitis.
     Dig Dis Sci. 2022 Jun 15. pii: 10.1007/s10620-022-07581.
     PubMed     Abstract available
     
     
     
147. OHNO A, Fujimori N, Kaku T, Takamatsu Y, et al
     Feasibility and Efficacy of Endoscopic Ultrasound-Guided Hepaticogastrostomy Without Dilation: A Propensity Score Matching Analysis.
     Dig Dis Sci. 2022 Jun 10. pii: 10.1007/s10620-022-07555.
     PubMed     Abstract available
     
     
     
148. DHIR V, Bale A
     EUS-Guided Hepatico-Gastrostomy: To Dilate or Not to Dilate?
     Dig Dis Sci. 2022 Jun 10. pii: 10.1007/s10620-022-07560.
     PubMed    
     
     
     
149. KUGELMAS M, Zapata I, Tawil J, Pessetto A, et al
     Liver Cirrhosis Increases the Risk of Developing Advanced Colon Polyps.
     Dig Dis Sci. 2022 Jun 7. pii: 10.1007/s10620-022-07561.
     PubMed     Abstract available
     
     
     
150. PAN AY, Zilberstein NF, Farnan JM, McConville JF, et al
     Recently Graduated Medical Students Lack Exposure to and Comfort with Chronic Liver Diseases.
     Dig Dis Sci. 2022;67:2081-2085.
     PubMed     Abstract available
     
     
     
151. TESTINO G, Vignoli T, Patussi V, Allosio P, et al
     Alcohol-Related Liver Disease in the Covid-19 Era: Position Paper of the Italian Society on Alcohol (SIA).
     Dig Dis Sci. 2022;67:1975-1986.
     PubMed     Abstract available
     
     
     
152. GLASS L, Asefa H, Volk M, Lok AS, et al
     Disease Knowledge, Health-Related Quality of Life, and Lifestyle Behavior Change in Patients with Nonalcoholic Fatty Liver Disease: Impact of an Educational Intervention.
     Dig Dis Sci. 2022;67:2123-2133.
     PubMed     Abstract available
     
     
     
153. NABI O, Boursier J, Lacombe K, Mathurin P, et al
     Comorbidities Are Associated with Fibrosis in NAFLD Subjects: A Nationwide Study (NASH-CO Study).
     Dig Dis Sci. 2022;67:2584-2593.
     PubMed     Abstract available
     
     
     
154. SIDDIQUI MA, Suresh S, Simmer S, Abu-Ghanimeh M, et al
     Increased Morbidity and Mortality in COVID-19 Patients with Liver Injury.
     Dig Dis Sci. 2022;67:2577-2583.
     PubMed     Abstract available
     
     
     May 2022
155. ASOTIBE JC, Banini BA
     Hepatic Hydrothorax: An Independent Predictor of Mortality in Cirrhosis? Is the MELD-Na Score Worth Its Salt?
     Dig Dis Sci. 2022 May 9. pii: 10.1007/s10620-022-07523.
     PubMed    
     
     
     
156. OSMAN KT, Abdelfattah AM, Mahmood SK, Elkhabiry L, et al
     Refractory Hepatic Hydrothorax Is an Independent Predictor of Mortality When Compared to Refractory Ascites.
     Dig Dis Sci. 2022 May 9. pii: 10.1007/s10620-022-07522.
     PubMed     Abstract available
     
     
     
157. AL-OBAID LN, Bazarbashi AN, Ryou M
     Variceal Bleeding: Beyond Banding.
     Dig Dis Sci. 2022;67:1442-1454.
     PubMed     Abstract available
     
     
     April 2022
158. B HADI Y, Khan RS, Lakhani DA, Khan AY, et al
     Antibiotic Prophylaxis for Upper Gastrointestinal Bleed in Liver Cirrhosis; Less May Be More.
     Dig Dis Sci. 2022 Apr 25. pii: 10.1007/s10620-022-07481.
     PubMed     Abstract available
     
     
     
159. ZHAO M, Ma L, Honda T, Kato A, et al
     Astaxanthin Attenuates Nonalcoholic Steatohepatitis with Downregulation of Osteoprotegerin in Ovariectomized Mice Fed Choline-Deficient High-Fat Diet.
     Dig Dis Sci. 2022 Apr 10. pii: 10.1007/s10620-022-07489.
     PubMed     Abstract available
     
     
     
160. NOBARANI S, Alaei-Shahmiri F, Aghili R, Malek M, et al
     Visceral Adipose Tissue and Non-alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes.
     Dig Dis Sci. 2022;67:1389-1398.
     PubMed     Abstract available
     
     
     
161. NOUREDDIN N, Noureddin M, Singh A, Alkhouri N, et al
     Progression of Nonalcoholic Fatty Liver Disease-Associated Fibrosis in a Large Cohort of Patients with Type 2 Diabetes.
     Dig Dis Sci. 2022;67:1379-1388.
     PubMed     Abstract available
     
     
     March 2022
162. TAKIGAWA A, Sakamori R, Tahata Y, Yoshioka T, et al
     Prediction Model for Intrahepatic Distant Recurrence After Radiofrequency Ablation for Primary Hepatocellular Carcinoma 2 cm or Smaller.
     Dig Dis Sci. 2022 Mar 30. pii: 10.1007/s10620-022-07455.
     PubMed     Abstract available
     
     
     
163. HENSON JB, Helzberg JH, Muir AJ
     Patient-Predicted Outcomes Are Associated with Quality of Life in Patients with Primary Sclerosing Cholangitis.
     Dig Dis Sci. 2022 Mar 28. pii: 10.1007/s10620-022-07482.
     PubMed     Abstract available
     
     
     
164. BUCSICS T, Lampichler K, Vierziger C, Schoder M, et al
     Covered Transjugular Intrahepatic Portosystemic Shunt Improves Hypersplenism-Associated Cytopenia in Cirrhosis.
     Dig Dis Sci. 2022 Mar 17. pii: 10.1007/s10620-022-07443.
     PubMed     Abstract available
     
     
     
165. RAMANI A, Tapper EB, Griffin C, Shankar N, et al
     Hepatocellular Carcinoma-Related Mortality in the USA, 1999-2018.
     Dig Dis Sci. 2022 Mar 14. pii: 10.1007/s10620-022-07433.
     PubMed     Abstract available
     
     
     
166. SINHA A, Bhuva M, Grant C, Gimson AE, et al
     ABCB4 Mutations in Adults Cause a Spectrum Cholestatic Disorder Histologically Distinct from Other Biliary Disease.
     Dig Dis Sci. 2022 Mar 14. pii: 10.1007/s10620-022-07416.
     PubMed     Abstract available
     
     
     
167. CHOI AY, Chang KJ, Samarasena JB, Lee JG, et al
     Endoscopic Ultrasound-Guided Porto-systemic Pressure Gradient Measurement Correlates with Histological Hepatic Fibrosis.
     Dig Dis Sci. 2022 Mar 12. pii: 10.1007/s10620-022-07418.
     PubMed     Abstract available
     
     
     
168. LEE TH, Hirshman N, Cardona DM, Berg CL, et al
     LR-3 and LR-4 Lesions Are More Likely to Be Hepatocellular Carcinoma in Transplant Patients with LR-5 or LR-TR Lesions.
     Dig Dis Sci. 2022 Mar 7. pii: 10.1007/s10620-022-07428.
     PubMed     Abstract available
     
     
     
169. ZHAO Z, Gao J, Huang S
     LncRNA SNHG7 Promotes the HCC Progression Through miR-122-5p/FOXK2 Axis.
     Dig Dis Sci. 2022;67:925-935.
     PubMed     Abstract available
     
     
     
170. BHURWAL A, Makar M, Patel A, Mutneja H, et al
     Safety and Efficacy of Thrombin for Bleeding Gastric Varices: A Systematic Review and Meta-Analysis.
     Dig Dis Sci. 2022;67:953-963.
     PubMed     Abstract available
     
     
     February 2022
171. DIBATTISTA JV, Burkholder DA, Lok AS, Chen VL, et al
     Accuracy of Non-invasive Indices for Diagnosing Hepatic Steatosis Compared to Imaging in a Real-World Cohort.
     Dig Dis Sci. 2022 Feb 15. pii: 10.1007/s10620-022-07415.
     PubMed     Abstract available
     
     
     
172. SINGH AD, Ford A, Lyu R, Layoun H, et al
     Impact of Cirrhotic Cardiomyopathy Diagnosed According to Different Criteria on Patients with Cirrhosis Awaiting Liver Transplantation: A Retrospective Cohort Study.
     Dig Dis Sci. 2022 Feb 12. pii: 10.1007/s10620-022-07412.
     PubMed     Abstract available
     
     
     
173. ROGAL SS, Chinman MJ, DeMonte W, Gibson S, et al
     Using Intervention Mapping to Develop a Novel Pain Self-Management Intervention for People with Cirrhosis.
     Dig Dis Sci. 2022 Feb 11. pii: 10.1007/s10620-022-07380.
     PubMed     Abstract available
     
     
     
174. SHENOY A, Louissaint J, Shannon C, Tapper EB, et al
     Viscoelastic Testing Prior to Non-surgical Procedures Reduces Blood Product Use Without Increasing Bleeding Risk in Cirrhosis.
     Dig Dis Sci. 2022 Feb 5. pii: 10.1007/s10620-021-07376.
     PubMed     Abstract available
     
     
     
175. JINDAL A, Sarin SK, Kumar M, Kumar G, et al
     Clinical Outcomes in Patients with Advanced Chronic Liver Disease and Hepatic Venous Pressure Gradient
     Dig Dis Sci. 2022 Feb 3. pii: 10.1007/s10620-021-07334.
     PubMed     Abstract available
     
     
     
176. GIBBS JT, Louissaint J, Tapper EB
     Rate of Successful Extubation in Mechanically Ventilated Patients with Cirrhosis and Hepatic Coma.
     Dig Dis Sci. 2022 Feb 2. pii: 10.1007/s10620-022-07400.
     PubMed     Abstract available
     
     
     
177. FAUST A, Stine JG
     Time to Step It Up: Mobile Health Intervention for Lifestyle Modification in Patients with Nonalcoholic Fatty Liver Disease.
     Dig Dis Sci. 2022;67:403-405.
     PubMed    
     
     
     
178. CHAUHAN M, Singh K, Thuluvath PJ
     Bariatric Surgery in NAFLD.
     Dig Dis Sci. 2022;67:408-422.
     PubMed     Abstract available
     
     
     
179. TINCOPA MA, Lyden A, Wong J, Jackson EA, et al
     Impact of a Pilot Structured Mobile Technology Based Lifestyle Intervention for Patients with Nonalcoholic Fatty Liver Disease.
     Dig Dis Sci. 2022;67:481-491.
     PubMed     Abstract available
     
     
     
180. LI Y, Chen C, Lu L, Guo W, et al
     Cadmium Exposure in Young Adulthood Is Associated with Risk of Nonalcoholic Fatty Liver Disease in Midlife.
     Dig Dis Sci. 2022;67:689-696.
     PubMed     Abstract available
     
     
     January 2022
181. GONZALEZ JJ, Dziwis J, Patel YA, Tapper EB, et al
     Identifying Ascites in Patients with Cirrhosis Using Administrative Codes and Diuretic Use: A Multicenter Study.
     Dig Dis Sci. 2022 Jan 28. pii: 10.1007/s10620-021-07367.
     PubMed     Abstract available
     
     
     
182. PARK MK, Lee YB, Moon H, Choi NR, et al
     Effectiveness of Lenvatinib Versus Sorafenib for Unresectable Hepatocellular Carcinoma in Patients with Hepatic Decompensation.
     Dig Dis Sci. 2022 Jan 20. pii: 10.1007/s10620-021-07365.
     PubMed     Abstract available
     
     
     
183. PANCHAL SA, Kaplan DE, Goldberg DS, Mahmud N, et al
     Algorithms to Identify Alcoholic Hepatitis Hospitalizations in Patients with Cirrhosis.
     Dig Dis Sci. 2022 Jan 13. pii: 10.1007/s10620-021-07321.
     PubMed     Abstract available
     
     
     
184. CHANDAN S, Deliwala S, Khan SR, Ramai D, et al
     Advanced Endoscopic Resection Techniques in Cirrhosis-A Systematic Review and Meta-Analysis of Outcomes.
     Dig Dis Sci. 2022 Jan 6. pii: 10.1007/s10620-021-07364.
     PubMed     Abstract available
     
     
     
185. WEGERMANN K, Wilder JM, Parish A, Niedzwiecki D, et al
     Racial and Socioeconomic Disparities in Utilization of Telehealth in Patients with Liver Disease During COVID-19.
     Dig Dis Sci. 2022;67:93-99.
     PubMed     Abstract available
     
     
     
186. WAHID N, Rosenblatt R
     Disparities in Telehealth for Liver Disease: Revealing What Was Hidden in Plain Sight.
     Dig Dis Sci. 2022;67:3-5.
     PubMed    
     
     
     
187. NAJAFIAN N, Weber AT, Zuckerman JE, Zhang S, et al
     AL Lambda Amyloidosis Activates Acute Liver Failure in the Absence of Plasma Cell Dyscrasia.
     Dig Dis Sci. 2022;67:67-70.
     PubMed     Abstract available
     
     
     
188. KHALIFA A, Sasso R, Rockey DC
     Role of Liver Biopsy in Assessment of Radiologically Identified Liver Masses.
     Dig Dis Sci. 2022;67:337-343.
     PubMed     Abstract available
     
     
     
189. WANGRATTANAPRANEE P, Khrucharoen U, Jensen DM, Wongpongsalee T, et al
     Severe Upper Gastrointestinal Hemorrhage Caused by Reflux Esophagitis.
     Dig Dis Sci. 2022;67:159-169.
     PubMed     Abstract available
     
     
     December 2021
190. JOHNSON KD, Perisetti A, Goyal H, Thandassery R, et al
     Liver Biopsy in Pregnancy: Two Case Reports and Review of the Literature.
     Dig Dis Sci. 2021;66:4090-4098.
     PubMed     Abstract available
     
     
     
191. YAN Y, Xing X, Wang X, Men R, et al
     Development and Validation of an Easy-to-Use Risk Scoring System for Screening High-Risk Varices in Patients with HBV-Related Compensated Advanced Chronic Liver Disease.
     Dig Dis Sci. 2021;66:4518-4524.
     PubMed     Abstract available
     
     
     
192. HIGUERA-DE-LA-TIJERA F, Cordova-Gallardo J, Buganza-Torio E, Barranco-Fragoso B, et al
     Hepamet Fibrosis Score in Nonalcoholic Fatty Liver Disease Patients in Mexico: Lower than Expected Positive Predictive Value.
     Dig Dis Sci. 2021;66:4501-4507.
     PubMed     Abstract available
     
     
     
193. DHALIWAL HS, Singh R, Abraham AM, Sharma R, et al
     Perception of Illness and Its Association with Treatment Willingness in Patients with Newly Diagnosed Nonalcoholic Fatty Liver Disease.
     Dig Dis Sci. 2021;66:4197-4207.
     PubMed     Abstract available
     
     
     November 2021
194. CHANG JI, Sinn DH, Cho H, Kim S, et al
     Clinical Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma Patients with Undetectable Serum HBV DNA Levels.
     Dig Dis Sci. 2021 Nov 20. pii: 10.1007/s10620-021-07312.
     PubMed     Abstract available
     
     
     
195. DONG TS, Jacobs JP, Agopian V, Pisegna JR, et al
     Duodenal Microbiome and Serum Metabolites Predict Hepatocellular Carcinoma in a Multicenter Cohort of Patients with Cirrhosis.
     Dig Dis Sci. 2021 Nov 20. pii: 10.1007/s10620-021-07299.
     PubMed     Abstract available
     
     
     
196. PODRUG K, Trkulja V, Zelenika M, Bokun T, et al
     Validation of the New Diagnostic Criteria for Clinically Significant Portal Hypertension by Platelets and Elastography.
     Dig Dis Sci. 2021 Nov 5. pii: 10.1007/s10620-021-07277.
     PubMed     Abstract available
     
     
     
197. BENITEZ C
     Pressure Measurements Under Pressure: Simplifying the Diagnosis of Clinically Significant Portal Hypertension.
     Dig Dis Sci. 2021 Nov 5. pii: 10.1007/s10620-021-07283.
     PubMed    
     
     
     
198. MANKA PP, Kaya E, Canbay A, Syn WK, et al
     A Review of the Epidemiology, Pathophysiology, and Efficacy of Anti-diabetic Drugs Used in the Treatment of Nonalcoholic Fatty Liver Disease.
     Dig Dis Sci. 2021;66:3676-3688.
     PubMed     Abstract available
     
     
     
199. KOSICK HM, Keyrouz A, Adeyi O, Sebastiani G, et al
     A Stepwise Algorithmic Approach and External Validation Study for Noninvasive Prediction of Advanced Fibrosis in Nonalcoholic Fatty Liver Disease.
     Dig Dis Sci. 2021;66:4046-4057.
     PubMed     Abstract available
     
     
     
200. ABDU B, Akolkar S, Picking C, Boura J, et al
     Factors Associated with Delayed Paracentesis in Patients with Spontaneous Bacterial Peritonitis.
     Dig Dis Sci. 2021;66:4035-4045.
     PubMed     Abstract available
     
     
     October 2021
201. BURKHOLDER DA, Moran IJ, DiBattista JV, Lok AS, et al
     Accuracy of International Classification of Diseases-10 Codes for Cirrhosis and Portal Hypertensive Complications.
     Dig Dis Sci. 2021 Oct 21. pii: 10.1007/s10620-021-07282.
     PubMed     Abstract available
     
     
     
202. LI W, Xue H, Li Y, Li P, et al
     HIPK3 Circular RNA Promotes Metastases of HCC Through Sponging miR-338-3p to Induce ZEB2 Expression.
     Dig Dis Sci. 2021;66:3439-3447.
     PubMed     Abstract available
     
     
     
203. STINE JG, Soriano C, Schreibman I, Rivas G, et al
     Breaking Down Barriers to Physical Activity in Patients with Nonalcoholic Fatty Liver Disease.
     Dig Dis Sci. 2021;66:3604-3611.
     PubMed     Abstract available
     
     
     September 2021
204. KONG J, Liang X, Zhang J, Zeng J, et al
     Antiviral Therapy Improves Survival in Hepatocellular Carcinoma with Microvascular Invasion: A Propensity Score Analysis.
     Dig Dis Sci. 2021 Sep 14. pii: 10.1007/s10620-021-07248.
     PubMed     Abstract available
     
     
     
205. LI J, Lu M, Zhou Y, Bowlus CL, et al
     Dynamic Risk Prediction of Response to Ursodeoxycholic Acid Among Patients with Primary Biliary Cholangitis in the USA.
     Dig Dis Sci. 2021 Sep 9. pii: 10.1007/s10620-021-07219.
     PubMed     Abstract available
     
     
     
206. JEON Y, Limketkai BN
     Arrested Development: Slow Progression of Fibrosis in Patients with NAFLD and IBD.
     Dig Dis Sci. 2021;66:2853-2854.
     PubMed    
     
     
     
207. LABENZ C, Kostev K, Kaps L, Galle PR, et al
     Incident Dementia in Elderly Patients with Nonalcoholic Fatty Liver Disease in Germany.
     Dig Dis Sci. 2021;66:3179-3185.
     PubMed     Abstract available
     
     
     
208. UFERE NN, Donlan J, Indriolo T, Richter J, et al
     Burdensome Transitions of Care for Patients with End-Stage Liver Disease and Their Caregivers.
     Dig Dis Sci. 2021;66:2942-2955.
     PubMed     Abstract available
     
     
     August 2021
209. YOPES MC, Mozeika AM, Liebling S, Haslam A, et al
     An Analysis of 5 Years of Randomized Trials in Gastroenterology and Hepatology Reveals 52 Medical Reversals.
     Dig Dis Sci. 2021 Aug 31. pii: 10.1007/s10620-021-07199.
     PubMed     Abstract available
     
     
     
210. HANSEN L, Chang MF, Hiatt S, Dieckmann NF, et al
     Symptom Frequency and Distress Underestimated in Decompensated Cirrhosis.
     Dig Dis Sci. 2021 Aug 27. pii: 10.1007/s10620-021-07216.
     PubMed     Abstract available
     
     
     
211. LOUISSAINT J, Kassab I, Yeboah-Korang A, Fontana RJ, et al
     Combining K-72 Hepatic Failure with 15 Individual T-Codes to Identify Patients with Idiosyncratic Drug-Induced Liver Injury in the Electronic Medical Record.
     Dig Dis Sci. 2021 Aug 24. pii: 10.1007/s10620-021-07223.
     PubMed     Abstract available
     
     
     
212. TRIVEDI HD, Niezen S, Jiang ZG, Tapper EB, et al
     Severe Hepatic Steatosis by Controlled Attenuation Parameter Predicts Quality of Life Independent of Fibrosis.
     Dig Dis Sci. 2021 Aug 21. pii: 10.1007/s10620-021-07228.
     PubMed     Abstract available
     
     
     
213. VIJAYARAGHAVAN R, Maiwall R, Arora V, Choudhary A, et al
     Reversal of Feed Intolerance by Prokinetics Improves Survival in Critically Ill Cirrhosis Patients.
     Dig Dis Sci. 2021 Aug 14. pii: 10.1007/s10620-021-07185.
     PubMed     Abstract available
     
     
     
214. ZHANG S, Tao X, Wang L, Chen H, et al
     Downregulation of Programmed Death-1 Pathway Promoting CD8 + T Cell Cytotoxicity in Primary Biliary Cholangitis.
     Dig Dis Sci. 2021 Aug 14. pii: 10.1007/s10620-021-07165.
     PubMed     Abstract available
     
     
     
215. CHEN Y, Li H, Chen D, Jiang X, et al
     Hypoxic Hepatocellular Carcinoma Cells Acquire Arsenic Trioxide Resistance by Upregulating HIF-1alpha Expression.
     Dig Dis Sci. 2021 Aug 12. pii: 10.1007/s10620-021-07202.
     PubMed     Abstract available
     
     
     
216. THAKER S, Mikolajczyk AE
     Concise Commentary: Are We Making a Difference? The Impact of Inpatient Gastroenterology and Hepatology Consultations for Cirrhotic Patients.
     Dig Dis Sci. 2021 Aug 10. pii: 10.1007/s10620-021-07171.
     PubMed    
     
     
     
217. SERPER M, Kaplan DE, Lin M, Taddei TH, et al
     Inpatient Gastroenterology Consultation and Outcomes of Cirrhosis-Related Hospitalizations in Two Large National Cohorts.
     Dig Dis Sci. 2021 Aug 10. pii: 10.1007/s10620-021-07150.
     PubMed     Abstract available
     
     
     
218. OH JH, Goh MJ, Park Y, Kim J, et al
     Different Performance of Liver Stiffness Measurement According to Etiology and Outcome for the Prediction of Liver-Related Events.
     Dig Dis Sci. 2021;66:2816-2825.
     PubMed     Abstract available
     
     
     
219. NOZAWA H, Emoto S, Sonoda H, Kawai K, et al
     Liver Injury Among Japanese Patients Treated Using Prophylactic Enoxaparin After Colorectal Surgery.
     Dig Dis Sci. 2021;66:2805-2815.
     PubMed     Abstract available
     
     
     July 2021
220. BOCKORNY B, Bullock AJ, Abrams TA, Faintuch S, et al
     Priming of Sorafenib Prior to Radiofrequency Ablation Does Not Increase Treatment Effect in Hepatocellular Carcinoma.
     Dig Dis Sci. 2021 Jul 23. pii: 10.1007/s10620-021-07156.
     PubMed     Abstract available
     
     
     
221. CULLARO G, Rubin JB, Fortune BE, Crawford CV, et al
     Association Between Kidney Dysfunction Types and Mortality Among Hospitalized Patients with Cirrhosis.
     Dig Dis Sci. 2021 Jul 22. pii: 10.1007/s10620-021-07159.
     PubMed     Abstract available
     
     
     
222. HAI Y, Chong W, Eisenbrey JR, Forsberg F, et al
     Network Meta-Analysis: Noninvasive Imaging Modalities for Identifying Clinically Significant Portal Hypertension.
     Dig Dis Sci. 2021 Jul 17. pii: 10.1007/s10620-021-07168.
     PubMed     Abstract available
     
     
     
223. BARNES EL, Grimm-Vavlitis JL, Long MD
     Impact of Virtual Interviews on Gastroenterology and Hepatology Fellowship Recruitment.
     Dig Dis Sci. 2021 Jul 15. pii: 10.1007/s10620-021-07123.
     PubMed    
     
     
     
224. LIU J, He X, Zou Y, Wang K, et al
     Circular RNA Circ-STIL Contributes to Cell Growth and Metastasis in Hepatocellular Carcinoma via Regulating miR-345-5p/AQP3 Axis.
     Dig Dis Sci. 2021 Jul 6. pii: 10.1007/s10620-021-07054.
     PubMed     Abstract available
     
     
     
225. MANKA P, Syn WK
     NASH, Metabolic Syndrome, and Diabetes: How Sugar and Fat Increase the Risk of Developing Advanced Liver Disease.
     Dig Dis Sci. 2021;66:2147-2148.
     PubMed    
     
     
     
226. BOPPANA V, Sahni S, Glass J, Chang C, et al
     HCC You Cannot See.
     Dig Dis Sci. 2021;66:2185-2189.
     PubMed    
     
     
     
227. MARTIN M, Zou B, Hoang J, Jeong D, et al
     Racial and Socioeconomic Disparities in Hospitalization of Pediatrics with Liver Disease from 2005 to 2015.
     Dig Dis Sci. 2021;66:2240-2249.
     PubMed     Abstract available
     
     
     June 2021
228. DELEURAN T, Watson H, Vilstrup H, Jepsen P, et al
     Risk Factors for Hepatic Hydrothorax in Cirrhosis Patients with Ascites - A Clinical Cohort Study.
     Dig Dis Sci. 2021 Jun 30. pii: 10.1007/s10620-021-07134.
     PubMed     Abstract available
     
     
     
229. CHAUHAN M, Zhang T, Thuluvath PJ
     Gender Differences in Liver Transplantation Outcomes in Polycystic Liver Disease.
     Dig Dis Sci. 2021 Jun 30. pii: 10.1007/s10620-021-07125.
     PubMed     Abstract available
     
     
     
230. CANCADO GGL, Braga MH, Ferraz MLG, Villela-Nogueira CA, et al
     Anti-mitochondrial Antibody-Negative Primary Biliary Cholangitis Is Part of the Same Spectrum of Classical Primary Biliary Cholangitis.
     Dig Dis Sci. 2021 Jun 28. pii: 10.1007/s10620-021-07122.
     PubMed     Abstract available
     
     
     
231. ZHOU K, Dodge JL, Yuan L, Terrault NA, et al
     Metabolic Risk Profiles for Hepatic Steatosis Differ by Race/Ethnicity: An Elastography-Based Study of US Adults.
     Dig Dis Sci. 2021 Jun 26. pii: 10.1007/s10620-021-07124.
     PubMed     Abstract available
     
     
     
232. FRENETTE CT, Levy C, Saab S
     Hepatic Encephalopathy-Related Hospitalizations in Cirrhosis: Transition of Care and Closing the Revolving Door.
     Dig Dis Sci. 2021 Jun 24. pii: 10.1007/s10620-021-07075.
     PubMed     Abstract available
     
     
     
233. HA NB, Cho SJ, Mohamad Y, Kent D, et al
     Visceral Adipose Tissue Inflammation and Radiographic Visceral-to-Subcutaneous Adipose Tissue Ratio in Patients with Cirrhosis.
     Dig Dis Sci. 2021 Jun 16. pii: 10.1007/s10620-021-07099.
     PubMed     Abstract available
     
     
     
234. DAHIYA M, Eboreime E, Hyde A, Rahman S, et al
     International Classification of Diseases Codes are Useful in Identifying Cirrhosis in Administrative Databases.
     Dig Dis Sci. 2021 Jun 6. pii: 10.1007/s10620-021-07076.
     PubMed     Abstract available
     
     
     
235. ZOU B, Yeo YH, Cheung R, Ingelsson E, et al
     Fatty Liver Index and Development of Cardiovascular Disease: Findings from the UK Biobank.
     Dig Dis Sci. 2021;66:2092-2100.
     PubMed     Abstract available
     
     
     
236. SHARMA A, Keshava SN, Eapen A, Elias E, et al
     An Update on the Management of Budd-Chiari Syndrome.
     Dig Dis Sci. 2021;66:1780-1790.
     PubMed     Abstract available
     
     
     May 2021
237. PENG X, Tian A, Li J, Mao Y, et al
     Diagnostic Value of FibroTouch and Non-invasive Fibrosis Indexes in Hepatic Fibrosis with Different Aetiologies.
     Dig Dis Sci. 2021 May 31. pii: 10.1007/s10620-021-07049.
     PubMed     Abstract available
     
     
     
238. CACCAMO G, Franze MS, Saffioti F, Pitrone C, et al
     Cirrhotic Patients with Bacterial Infection and Negative Cultures Have a More Advanced Disease and an Increased Short-Term Mortality Rate.
     Dig Dis Sci. 2021 May 26. pii: 10.1007/s10620-021-07047.
     PubMed     Abstract available
     
     
     
239. PINYOPORNPANISH K, Al-Yaman W, Dasarathy S, Romero-Marrero C, et al
     Hepatocellular Carcinoma in Patients Without Cirrhosis: The Fibrosis Stage Distribution, Characteristics and Survival.
     Dig Dis Sci. 2021 May 23. pii: 10.1007/s10620-021-07048.
     PubMed     Abstract available
     
     
     
240. LI X, Lv J, Hou L, Guo X, et al
     Circ_0001955 Acts as a miR-646 Sponge to Promote the Proliferation, Metastasis and Angiogenesis of Hepatocellular Carcinoma.
     Dig Dis Sci. 2021 May 22. pii: 10.1007/s10620-021-07053.
     PubMed     Abstract available
     
     
     
241. SERPER M
     Monitoring for Ascites in Cirrhosis Using Patient-Generated Health Data: No Longer a Remote Possibility.
     Dig Dis Sci. 2021 May 18. pii: 10.1007/s10620-021-07020.
     PubMed    
     
     
     
242. YU B, Zhou S, Liang H, Ye Q, et al
     Development and Validation of a Novel Circulating miRNA-Based Diagnostic Score for Early Detection of Hepatocellular Carcinoma.
     Dig Dis Sci. 2021 May 12. pii: 10.1007/s10620-021-07031.
     PubMed     Abstract available
     
     
     
243. ARTEEL GE, Singhvi A, Feldman R, Althouse AD, et al
     Coexistent Alcohol-Related Liver Disease and Alcohol-Related Pancreatitis: Analysis of a Large Heath Care System Cohort.
     Dig Dis Sci. 2021 May 7. pii: 10.1007/s10620-021-07010.
     PubMed     Abstract available
     
     
     
244. BLOOM PP, Ventoso M, Tapper E, Ha J, et al
     A Telemonitoring Intervention for Cirrhotic Ascites Management Is Cost-Saving.
     Dig Dis Sci. 2021 May 6. pii: 10.1007/s10620-021-07013.
     PubMed     Abstract available
     
     
     
245. TO C, Liu L, Satoskar RS, Thuluvath PJ, et al
     Diabetic Hepatosclerosis in a Woman with Maturity-Onset Diabetes of the Young Type 3.
     Dig Dis Sci. 2021 May 3. pii: 10.1007/s10620-021-07005.
     PubMed    
     
     
     
246. RICH NE, Parvathaneni A, Sen A, Odewole M, et al
     High Neutrophil-Lymphocyte Ratio and Delta Neutrophil-Lymphocyte Ratio Are Associated with Increased Mortality in Patients with Hepatocellular Cancer.
     Dig Dis Sci. 2021 May 3. pii: 10.1007/s10620-021-07001.
     PubMed     Abstract available
     
     
     
247. HASHIMOTO R, Lee DP, Samarasena JB, Chandan VS, et al
     Comparison of Two Specialized Histology Needles for Endoscopic Ultrasound (EUS)-Guided Liver Biopsy: A Pilot Study.
     Dig Dis Sci. 2021;66:1700-1706.
     PubMed     Abstract available
     
     
     April 2021
248. SCHEWE J, Makeschin MC, Khandoga A, Zhang J, et al
     To Protect Fatty Livers from Ischemia Reperfusion Injury: Role of Ischemic Postconditioning.
     Dig Dis Sci. 2021;66:1349-1359.
     PubMed     Abstract available
     
     
     
249. TROWELL J, Alukal J, Zhang T, Liu L, et al
     How Good Are Controlled Attenuation Parameter Scores from Fibroscan to Assess Steatosis, NASH, and Fibrosis?
     Dig Dis Sci. 2021;66:1297-1305.
     PubMed     Abstract available
     
     
     
250. SINGAL AK, Ahmed Z, Axley P, Arora S, et al
     Hospitalizations for Acute on Chronic Liver Failure at Academic Compared to Non-academic Centers Have Higher Mortality.
     Dig Dis Sci. 2021;66:1306-1314.
     PubMed     Abstract available
     
     
     February 2021
251. ZHOU SN, Pan WT, Pan MX, Luo QY, et al
     Comparison of Immune Microenvironment Between Colon and Liver Metastatic Tissue in Colon Cancer Patients with Liver Metastasis.
     Dig Dis Sci. 2021;66:474-482.
     PubMed     Abstract available
     
     
     
252. PATIDAR KR, Davis BC, Slaven JE, Ghabril MS, et al
     Admission Factor V Predicts Transplant-Free Survival in Acute Liver Failure.
     Dig Dis Sci. 2021;66:619-627.
     PubMed     Abstract available
     
     
     January 2021
253. CAVAZZA A, McPhail MJ
     Absolutely FABulous? FABP-1 in Non-acetaminophen-related Acute Liver Failure.
     Dig Dis Sci. 2021;66:10-11.
     PubMed    
     
     
     
254. ABBASS A, Khalid S, Farooq U, Rakov N, et al
     If DILI Is Suspected, Don't Dally.
     Dig Dis Sci. 2021;66:52-55.
     PubMed    
     
     
     
255. PATEL HK, Saxena R, Rush N, Patel SK, et al
     A Comparative Study of 22G versus 19G Needles for EUS-Guided Biopsies for Parenchymal Liver Disease: Are Thinner Needles Better?
     Dig Dis Sci. 2021;66:238-246.
     PubMed     Abstract available
     
     
     
256. KARVELLAS CJ, Speiser JL, Tremblay M, Lee WM, et al
     Elevated Serum Liver-Type Fatty Acid Binding Protein Levels in Non-acetaminophen Acute Liver Failure Patients with Organ Dysfunction.
     Dig Dis Sci. 2021;66:273-283.
     PubMed     Abstract available
     
     
     
257. KIM D, Yoo ER, Li AA, Tighe SP, et al
     Trends in Hospitalizations for Clostridioides difficile Infection in End-Stage Liver Disease, 2005-2014.
     Dig Dis Sci. 2021;66:296-307.
     PubMed     Abstract available
     
     
     August 2020
258. PHAW NA, Dyson JK, Mells G, Jones D, et al
     Understanding Fatigue in Primary Biliary Cholangitis.
     Dig Dis Sci. 2020 Aug 26. pii: 10.1007/s10620-020-06502.
     PubMed     Abstract available
     
     
     
259. PALERMO A, Gerussi A, Mulinacci G, Invernizzi P, et al
     Identifying Racial Disparities in Primary Biliary Cholangitis Patients: A Step Toward Achieving Equitable Outcomes Among All.
     Dig Dis Sci. 2020 Aug 13. pii: 10.1007/s10620-020-06528.
     PubMed    
     
     
     July 2020
260. AMJAD W, Alukal J, Zhang T, Maheshwari A, et al
     Two-Dose Hepatitis B Vaccine (Heplisav-B) Results in Better Seroconversion Than Three-Dose Vaccine (Engerix-B) in Chronic Liver Disease.
     Dig Dis Sci. 2020 Jul 2. pii: 10.1007/s10620-020-06437.
     PubMed     Abstract available
     
     
     June 2020
261. YUE W, Liu Y, Jiang W, Huang J, et al
     Prealbumin and D-dimer as Prognostic Indicators for Rebleeding in Patients with Nonvariceal Upper Gastrointestinal Bleeding.
     Dig Dis Sci. 2020 Jun 24. pii: 10.1007/s10620-020-06420.
     PubMed     Abstract available
     
     
     
262. ADEJUMO AC, Akhtar DH, Dennis BB, Cholankeril G, et al
     Gender and Racial Differences in Hospitalizations for Primary Biliary Cholangitis in the USA.
     Dig Dis Sci. 2020 Jun 13. pii: 10.1007/s10620-020-06402.
     PubMed     Abstract available
     
     
     
263. WANG CW, Lebsack A, Sudore RL, Lai JC, et al
     Low Rates of Advance Care Planning (ACP) Discussions Despite Readiness to Engage in ACP Among Liver Transplant Candidates.
     Dig Dis Sci. 2020 Jun 4. pii: 10.1007/s10620-020-06369.
     PubMed     Abstract available
     
     
     May 2020
264. SHROFF H, Rinella ME
     Thanks to CLD for Small Favors: Reduced CVD Risk in Patients Awaiting Liver Transplantation.
     Dig Dis Sci. 2020 May 29. pii: 10.1007/s10620-020-06322.
     PubMed    
     
     
     
265. NAGAOKA K, Ogawa K, Ji C, Cao KY, et al
     Targeting Aspartate Beta-Hydroxylase with the Small Molecule Inhibitor MO-I-1182 Suppresses Cholangiocarcinoma Metastasis.
     Dig Dis Sci. 2020 May 22. pii: 10.1007/s10620-020-06330.
     PubMed     Abstract available
     
     
     April 2020
266. ACHARYA C, White MB, Fagan A, Sterling RK, et al
     Liver Transplant Is Associated with Sustained Improvement in Tandem Gait and Risk of Falls.
     Dig Dis Sci. 2020 Apr 22. pii: 10.1007/s10620-020-06261.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge.